企業プロフィール
Savara, Inc. 株価・ニュース・カタリスト
- ティッカー:
- SVRA
- 取引所:
- NASDAQ
- セクター:
- Biopharma
- 所在地:
- United States
株価パフォーマンス
5.56 USD (-0.54%)
終値
最終更新: 2026年8月24日
1.08B USD
時価総額
株価変動の要因
As of Aug 24, 2026, SVRA closed down 0.54% at $5.56. No new same-company headline was identified in the current news window.
企業概要
事業概要
Savara is a respiratory company focused on rare lung disease and inhaled therapies. Its story is built around severe pulmonary conditions with limited treatment options.
所在地とセクター分類
Headquartered in the United States and listed on NASDAQ, Savara sits in specialty biopharma.
ビジネスモデルの特徴
The company depends on clinical data, inhaled-delivery execution, and the ability to build a rare-respiratory franchise.
バイオ業界での位置付け
Savara is a niche respiratory biotech whose stock is tightly linked to trial and regulatory progress.
今後のカタリスト
- Savara’s next catalyst is MOLBREEVI in autoimmune pulmonary alveolar proteinosis, with regulatory and launch-readiness steps doing most of the work. The key question is whether the program can keep moving toward a real rare-disease commercial opportunity.
最近のニュース
- 01
- 02
- 03
- 04
- 05
類似銘柄
事業成熟度、治療領域、カタリスト傾向が近い同業銘柄です。